iBio
IBIO
$2.02
Share price
-0.50%
Change (1 day)
83.63%
Change (1 year)
Categories
Operating Margin for iBio (IBIO)
Operating Margin as of May 2024 (TTM): -2,110.95%
According to iBio's latest financial reports and stock price the company's current Operating Margin is -2,110.95%. At the end of 2022 the company had an Operating Margin of -2,110.95%.
Operating Margin history for iBio from 2008 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -2,110.95% | 115.61% |
| 2021 | -979.04% | -2.48% |
| 2020 | -1,003.91% | 15.13% |
| 2019 | -872.00% | -75.96% |
| 2018 | -3,627.93% | -11.43% |
| 2017 | -4,096.19% | 264.38% |
| 2016 | -1,124.16% | 214.08% |
| 2015 | -357.91% | -79.99% |
| 2014 | -1,788.29% | 190.55% |
| 2013 | -615.49% | -15.71% |
| 2012 | -730.19% | -60.66% |
| 2011 | -1,856.25% | |
| 2009 | -161.97% | -14.3% |
| 2008 | -189.00% | 1.73% |
| 2007 | -185.79% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -101.08% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | -1,084.89% | -48.61% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | -396.48% | -81.22% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 17.53% | -100.83% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.